Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

BioAlliance Pharma provides update on AMEP biotherapy

April 30, 2012

Novel PLK1 inhibitor exhibits antitumor activity in vivo

April 30, 2012

FDA approves sNDA for Votrient

April 30, 2012

Investigation at Bionature yields novel candidate oncolytics

April 27, 2012

Novartis extends oncology discovery research collaboration

April 27, 2012

Phase I trial tests once-daily and intermittent INK-128 dosing

April 27, 2012

Epizyme forms strategic partnership with Celgene

April 27, 2012

Phase I trial studies vandetanib combination therapy for brain cancer

April 27, 2012

U.S. university patents new candidate vaccine adjuvants

April 27, 2012

Eisai reports launch of Halaven in Canada

April 26, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...